Mukka Proteins Secures US FDA Facility Registration
Mukka Proteins Ltd 路 Others (Uncategorized) 路 27 Oct 2026, 11:16 pm
Mukka Proteins Secures US FDA Facility Registration Mukka Proteins Limited has received a Certificate of Registration from Registrar Corp, Virginia, USA, confirming the registration of its facility with the U.S. FDA under the Federal Food, Drug, and Cosmetic Act. The registration is valid from 1st Oct'26 through 31st Dec'27. This regulatory milestone supports the company's business operations and enables commercial engagement with customers and target markets requiring mandatory U.S. FDA facility registration.
Original exchange filing (PDF)
More announcements from Mukka Proteins Ltd
- Intimation of Investor Presentation - Q2 & FY-27. 路 10 Nov 2026
- Intimation of Press Release. 路 08 Nov 2026
- Intimation of revision of terms of investment in Swachha Eco Solutions Private Limited. 路 07 Nov 2026
- Financial Results for the quarter and half year ended 30th September 2026. 路 07 Nov 2026
- Mukka Proteins Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 07 Nov 2026
- Intimation of Statement of Deviation and Variation for the quarter ended 30th September 2026. 路 07 Nov 2026
- Intimation of Outcome of Board Meeting 路 07 Nov 2026
- MUKKA PROTEINS LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 07 Nov 2026
